REG - Aukett Swanke Group - AIM Rule 17 Schedule 2(g) Update

Aukett SwankeAnnouncement

02/11/2020 07:05

RNS Number : 8336D
  
Aukett Swanke Group PLC
  
02 November 2020
  
 

Aukett Swanke Group Plc
AIM Rule 17 Schedule 2(g) Update
 
Aukett Swanke Group Plc (the "Group"), the international group of architects, interior designers and engineers, announces the following information relating to director disclosure under Schedule Two, Paragraph (g) of the AIM Rules for Companies.
On 10 May 2019, in relation to the appointment of Clive Carver as a Non-Executive Director, the Company disclosed certain directorships under Schedule Two, Paragraph (g) of the AIM Rules for Companies. In addition to those previously disclosed, Clive Carver was also a director of Appscatter Limited and Roxi Petroleum Limited within five years prior to his appointment.
In addition, Nicholas Thompson, chief executive officer of the Company, has informed the Company that Thompson & Newman Limited, of which he was director, was dissolved by Members Voluntary Liquidation in November 2016 with a shortfall to creditors of approximately £219,000.
 
 Enquiries:
Aukett Swanke Group Plc - 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Antony Barkwith, Group Financial Director
finnCap - 020 7220 0500

Corporate Finance: Julian Blunt/Giles Rolls

Corporate Broking:  Alice Lane
Investor / Media enquiries

Chris Steele 07979 604687

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RDNURRBRRBUROAA